Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081982 | SCV000113917 | benign | not specified | 2018-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081982 | SCV000517502 | benign | not specified | 2015-12-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001516759 | SCV001725101 | benign | ALG1-congenital disorder of glycosylation | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001516759 | SCV001769193 | benign | ALG1-congenital disorder of glycosylation | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000081982 | SCV002500484 | benign | not specified | 2022-03-18 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000081982 | SCV001739860 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000081982 | SCV001952078 | benign | not specified | no assertion criteria provided | clinical testing |